AdvaMed Names New Board Chairman

The Advanced Medical Technology Association (AdvaMed) today announced that David C. Dvorak, president and CEO of Zimmer Holdings Inc., has been named as the Washington, D.C.-based trade group’s board chairman for a two-year term.

Dvorak succeeds Abbott Medical Optics President Jim Mazzo, who has led the organization since 2008.
 
Dvorak has been an active member of the AdvaMed board since 2006 and has served as the chair of the association’s Orthopedics Sector since 2004. For the past two years he chaired AdvaMed’s Payment & Health Care Delivery Committee, where he led the association’s efforts to ensure that new payment delivery programs—such as accountable care organizations and bundling systems—support medical innovation and preserve patient/physician choice.
 
“It is an honor to be chosen to lead AdvaMed as nations around the world face a number of challenges that medical technology can help to solve, including the growing need for clinically-relevant and affordable healthcare solutions,” said Dvorak. “AdvaMed will partner with governments and sister organizations around the world to help aging populations facing the burden of costly chronic diseases. We can do this by harnessing the benefits of medical technology.”
 
According to AdvaMed, during his tenure Dvorak will focus on strategic initiatives that will:
 
• Achieve the Association’s highest priority advocacy issues, such as working with the U.S. Food and Drug Administration to ensure successful implementation of the new user fee agreement and repealing the medical device excise tax;
• Enhance AdvaMed’s advocacy efforts in emerging markets such as China, India and Brazil;
• Further build on the group’s relationships with patient and physician groups and other key stakeholders; and
• Strengthen AdvaMed’s in-house research capacity in order to better inform policymakers, the news media and the general public.

“AdvaMed is fortunate to have such a dynamic and committed advocate for medical innovation and patient care as its new chair,” said AdvaMed President and CEO Stephen J. Ubl. “David brings nearly a decade of experience with the Association to the job and a comprehensive understanding of the issues that impact the medical technology industry.”

Ubl thanked Mazzo for his “dedication and passion” to the industry and AdvaMed.
 
AdvaMed also announced new committee and Board chairs for 2012-2014:
 
• Nominating Committee – James V. Mazzo, president, Abbott Medical Optics
• Treasurer & Finance, Audit & Compensation Committee – David B. Perez, president and CEO, Terumo BCT
• Secretary – Joe E. Almeida, president and CEO, Covidien
• Payment & Healthcare Delivery – Jeffrey R. Binder, president and CEO, Biomet
* Technology & Regulation – Timothy M. Ring, chairman and CEO, C. R. Bard
• International – Kieran T. Gallahue, chairman and CEO, CareFusion
• Membership – Michael A. Lynch, CEO, Medical Segment, Cardinal Health
• Legal Committee – D. Cameron Findlay, senior vice president, general counsel and secretary, Medtronic
• AdvaMed PAC – Michael F. Mahoney, president, Boston Scientific
• Emerging Growth Company Council – Michael R. Minogue, chairman, president and CEO, Abiomed
• AdvaMedDx – Vincent A. Forlenza, president and CEO, BD